Nutex Health Q3 revenue surges, driven by hospital division

Nutex Health

19/11/2025 21:39

Overview

Nutex Health Q3 revenue increased 239.9% to $267.8 mln, driven by hospital division

Net income for Q3 rose to $55.4 mln from a loss of $8.8 mln in 2024

The healthcare management firm regained Nasdaq compliance, closing previous listing rule matter

Outlook

Company did not provide specific future guidance in the press release

Result Drivers

HOSPITAL DIVISION GROWTH - Revenue from hospital division increased significantly due to higher acuity claims and success in IDR process

ARBITRATION SUCCESS - Co achieved high success rate in arbitration, winning over 85% of claims and collecting over 80% of wins

STOCK COMPENSATION IMPACT - High stock-based compensation expenses due to obligations for under-construction hospitals

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Net Income
$96.80 mln
Q3 EBIT
$130.37 mln
Q3 Gross Profit
$154.88 mln
Q3 Pretax Profit
$123.94 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

Wall Street's median 12-month price target for Nutex Health Inc is $220.00, about 54.9% above its November 18 closing price of $99.20

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nPn9ZN16Ba

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)